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Crohn’s disease is a chronic relapsing and 
remitting inflammation of the bowel involving all 
its layers (13). A small bowel adenocarcinoma in 
Crohn’s disease was first described by Ginsburg et 
al. in 1956 (6). Since then an increasing number of 
cases have been identified (7). It is a rare complication 
of Crohn’s disease that typically involves the ileum. 
The data, however, are limited and based on case 
reports, retrospective studies, and reviews of the 
literature (4). The symptoms are often nonspecific 
and the diagnosis is usually delayed. As a result, 
infiltration and possible extension into adjacent 
tissues are common findings (4). The patients often 
complain of abdominal pain, weight loss, anorexia, 
bleeding and perforations. In general, localized 
adenocarcinomas of the small bowel are best 
managed with wide segmental surgical resection. 
The role of adjuvant chemotherapy for small 
intestine adenocarcinomas remains undefined. 
Scanty data suggest that they are sensitive to 5-FU- 
and irinotecan-based chemotherapy (5,10,11). The 
adjuvant chemotherapy used is similar to that 
for colorectal cancer. The prognosis of Crohn’s 
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ABSTRACT
Crohn’s disease is a chronic relapsing and remitting inflammation of the bowel involving all its layers. A small 
bowel adenocarcinoma in Crohn’s disease is a rare entity. The literature about this disease is reviewed. A case 
report of a 41-year male patient illustrates the significance of the diagnostic and therapeutic procedures.
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adenocarcinoma of the small bowel remains 
disturbingly poor. Negative prognostic factors for 
survival include positive surgical margins for cancer, 
lymph node metastases, extramural venous spread 
and poor tumour differentiation (1). Regional node 
metastases are more common in jejunal or ileal 
adenocarcinomas (2,9).
Despite advances in imaging and therapeutic 
techniques, one- and two-year mortality rates range 
between 30% and 60%, depending on the stage of 
disease (8,12). According to the Bulgarian national 
cancer registry in 2009 (3), the number of new small 
intestine cancer cases is 44 (17 females and 27 males), 
without specifying the presence of Crohn’s disease.
Table 1 shows cancer incidence rates per 100000 
inhabitants in Bulgaria and abroad.
The information about Crohn’s disease 
associated with adenocarcinoma is poorly represented 
in the Bulgarian medical literature.
Table 2 demonstrates the clinical characteristics 
in 157 previously reported cases of small bowel 
carcinoma in Crohn’s disease (4).
Table 1. cancer incidence rates per 100000 inhabitants 
Gender Bulgaria World standardized rate
males 0,7 0,4
females 0,4 0,2
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That’s why patients with documented Crohn’s 
disease in whom symptoms referable to the upper 
gastrointestinal tract develop should undergo 
diagnostic examination including barium and CT 
scanning as the results from endoscopy and biopsy 
can be vague or misleading.
Case report
This case is a proof that a small bowel 
carcinoma associated with Crohn’ disease is rare. 
A 41-year-old male presented to the Department of 
Internal Medicine in November 2010 with a history 
of referred intermittent episodes of abdominal pain 
and diarrhea for the last few years. He was admitted 
with a working diagnosis of ‘Crohn’s disease’ and 
corticosteroids were administered. During the last 
week the abdominal pain became more severe. 
Physical examination showed tenderness in the 
epigastrium and the right lower quadrant on the 
palpation with positive peritoneal irritation. Blood 
tests didn’t show any signs of inflammation. 
Abdominal x-rays showed air-fluid levels. 
Abdominal ultrasound performed for reassessment 
of the disease displayed a small bowel structure in the 
ileocecal region and dilated small bowel loops (Fig. 1). 
Abdominal CT scan revealed 8-mm ileum wall 
thickness, fluid-filled loops in the small intestine, 
a small amount of visible air in those loops and 
enlarged mesenteric and retroperitoneal lymph 
nodes (Fig. 2).
After acute aggravation of patient’s status, he 
underwent urgent surgery.
During laparotomy, purulent exudate in 
the pelvis (300 mL) as well as extremely dilated 
small bowel loops with adhesion and high-grade 
inflammatory alteration were identified. Besides there 
were a 2-cm perforation of the ileum, retroperitoneal 
appendix with thick wall, multiple lymph nodes, 
subdiaphragmatic collection of purulent exudate 
(100 mL) and pancreatic edema with hemorrhagic 
collection.
The following operations were performed: 
laparotomy, debridement, resection of the terminal 
ileum (100 cm3), right hemicolectomy with continuity 
restored by side-to-side ileotransversal anastomosis, 
cholecystectomy, abdominal lavage and drainage.
The histological examinations revealed sings 
of Crohn’s disease with fissuring and formation 
of fistulae, ‘skip lesions, a ring-cell carcinoma 
infiltrating the muscularis propria and subserosa of 
the ileum, tumour emboli into lymph and venous 
vessels of the subserosa, and tumour emboli in the 
appendix. one out of 20 lymph nodes removed was 
positive for a metastasis of a poorly differentiated 
adenocarcinoma. The surgical margins were negative 
for cancer.
The patient recovered well from surgery and 
underwent 4 cycles of FoLFox chemotherapy.
total number of patients 157
duration of Crohn’s disease before 
diagnosis of cancer (range and mean)
0-48 (19,0)








primary anastomosis site 3
other
perforation at presentation 1
Table 2. clinical characteristics in 157 previously reported 
cases of small bowel carcinoma in crohn’s disease (4)
fig. 1. Abdominal ultrasound images
fig. 2. Abdominal cT images
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In September 2011, during the follow-up, the 
patient complained of abdominal distention, pain in 
the left lower quadrant and constipation. There was 
a physical evidence of large amounts of ascitic fluid. 
The abdominal ultrasound showed a conglomeration 
of bowel loops, dilated common bile duct at the level 
of papilla Vateri, bilateral compression of the ureters 
at the level of the pelvic floor and ascites.  After the 
evacuation of the ascitic fluid, patient’s general status 
became stable and he was discharged with normal 
bowel function. It was accepted to be a cytologically 
proven ascites of cancer origin.
In october 2011, the patient was hospitalized 
again in the Department of Surgery with severe 
abdominal pain and vomiting. The abdominal x-
rays showed air-fluid levels in the small bowel. With 
symptoms and signs of acute abdomen, he underwent 
emergency surgery. The exploratory laparatomy 
identified a conglomeration of small bowel loops 
without clear demarcation line between them, thick 
descending and sigmoid colon, and carcinosis of the 
parietal peritoneum mainly expressed in the upper 
part of the abdomen. Enterostomy was performed 
for the most dilated small bowel loop for upper 
gastrointestinal tract decompression. There were no 
other possible options for its reconstruction. After 
surgery, the patient was administered parenteral 
nutrition, painkillers and additional symptomatic 
therapy. In spite of restored motility and functional 
enterostoma, he died one year after the first operation 
because of multiple organ failure. 
It can be concluded that Crohn’s disease 
associated with small bowel adenocarcinoma leads 
to progressive multiple organ failure due to bowel 
stricture, fistulae and perforation, on the one hand, 
and due to carcinoma intoxication, on the other hand.
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